FemPulse has recently achieved a significant milestone by obtaining an investigational device exemption (IDE) from the US Food and Drug Administration (FDA). This approval allows the company to conduct a pivotal clinical trial for its neuromodulation system designed to treat overactive bladder
Plastic pollution has emerged as one of the most pressing environmental and public health crises of our time. The pervasive presence of plastics in our environment, coupled with their detrimental health impacts, necessitates urgent global action. This article delves into the multifaceted issues
The recent partnership between African Export-Import Bank (Afreximbank) and Med Aditus Pharmaceutical Kenya Limited (Med Aditus) marks a significant milestone in the pharmaceutical industry in Kenya. This collaboration aims to boost local pharmaceutical production, ensuring access to affordable and
The National Institutes of Health (NIH) remains the primary federal agency responsible for conducting and supporting medical research in the United States. It allocates research funding through various mechanisms, with the study section peer review system being one of the key methods. This system
The recent selection of health officials by President-elect Donald Trump marks a significant shift in the U.S. approach to public health, with many of these nominees having been openly critical of the Biden administration's handling of the COVID-19 pandemic. This notable trend underscores a broader
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) has garnered notable attention from various research firms recently, leading to an overall consensus rating of "Moderate Buy." The evaluation by these firms reflects a mixture of ratings, with one analyst assigning a hold rating and five others issuing a buy
